limertinib from MedChemExpress

limertinib (ASK120067) is a potent and orally active inhibitor of EGFR^T790M (IC₅₀:0.3 nM) with selectivity over EGFR^WT (IC₅₀:6.0 nM). limertinib is a third-generation EGFR-TKI for the research of non-small cell lung cancer (NSCLC)